Connect your AI

UFP Technologies UFPT Operating Lease Liability - Undiscounted Excess Amount

Operating Lease Liability - Undiscounted Excess Amount at other companies

West Pharmaceutical ServicesWST

——

Other financials

Income statement

Revenue$154.2M+4.1%

Gross profit$44.4M+5.2%

Operating income$23.4M+1.0%

Net income$17.5M+1.8%

EPS (diluted)$2.24+1.4%

Balance sheet

Cash & equivalents$20.0M+42.4%

Total debt$156.1M-21.4%

Total equity$438.9M+21.7%

Total assets$674.7M+5.0%

Cash flow

Operating cash flow$3.2M-76.8%

CapEx$2.9M+3.1%

Free cash flow$22.5M+151%

Valuation

Market cap$1.88B-3.6%

Profitability

Gross margin28.4%-0.6pp

Operating margin15.2%-0.9pp

Net margin11.3%-0.3pp

FCF margin12.3%+2.0pp

Returns & leverage

Return on equity17.2%-2.2pp

Debt / equity0.4×-0.2×

Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's operating lease liability - undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is UFP Technologies's operating lease liability - undiscounted excess amount?: UFP Technologies (UFPT) reported operating lease liability - undiscounted excess amount of $2.89M in Q1 2026.
What does operating lease liability - undiscounted excess amount mean?: This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.